1. Home
  2. FOUR vs TXG Comparison

FOUR vs TXG Comparison

Compare FOUR & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shift4 Payments Inc.

FOUR

Shift4 Payments Inc.

HOLD

Current Price

$40.87

Market Cap

3.0B

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$18.25

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOUR
TXG
Founded
1999
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
FOUR
TXG
Price
$40.87
$18.25
Analyst Decision
Buy
Hold
Analyst Count
23
14
Target Price
$87.35
$17.18
AVG Volume (30 Days)
2.5M
2.2M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
76.97
EPS
N/A
N/A
Revenue
$4,180,000,000.00
$245,893,000.00
Revenue This Year
$24.90
N/A
Revenue Next Year
$14.56
$7.26
P/E Ratio
$27.53
N/A
Revenue Growth
25.50
68.06
52 Week Low
$41.65
$6.78
52 Week High
$107.16
$23.56

Technical Indicators

Market Signals
Indicator
FOUR
TXG
Relative Strength Index (RSI) 29.97 43.58
Support Level N/A $17.26
Resistance Level $76.31 $20.62
Average True Range (ATR) 2.13 1.27
MACD -0.21 -0.36
Stochastic Oscillator 0.21 31.49

Price Performance

Historical Comparison
FOUR
TXG

About FOUR Shift4 Payments Inc.

Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: